Literature DB >> 14769488

Implications of impaired ketogenesis in fatty acid oxidation disorders.

Simon Edward Olpin1.   

Abstract

Long-chain fatty acids are important sources of respiratory fuel for many tissues and during fasting the rate of hepatic production of ketone bodies is markedly increased. Many extra hepatic tissues utilize ketone bodies in the fasted state with the advantage that glucose is "spared" for more vital tissues like the brain. This glucose sparing effect of ketones is especially important in infants where there is a high proportional glucose utilization in cerebral tissue. The first reported inherited defect affecting fatty acid oxidation was described in 1973 and to date about 15 separate disorders have been described. Although individually rare, cumulatively fatty acid oxidation defects are relatively common, have major consequences for affected individuals and their families, and carry significant health care implications. The major biochemical consequence of fatty acid oxidation defects is an inability of extra hepatic tissues to utilize fatty acids as an energy source with absent or limited hepatic capacity to generate ketones. Clinically patients usually present in infancy with acute life-threatening hypoketotic hypoglycaemia, liver disease, hyperammonaemia and cerebral oedema, with or without cardiac involvement, usually following a period of catabolic stress. Chronically there may be muscle involvement with hypotonia or exercise intolerance with or without cardiomyopathy. Treatment is generally by the avoidance of fasting, frequent carbohydrate rich feeds and for long-chain defects, the replacement of long-chain dietary fats with medium-chain formulae. Novel approaches to treatment include the use of d,l-3-hydoxybutyrate or heptanoate as an alternative energy source.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769488     DOI: 10.1016/j.plefa.2003.06.003

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  11 in total

1.  Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.

Authors:  Hironori Nagasaka; Ken-ichi Hirano; Akira Ohtake; Takashi Miida; Tomozumi Takatani; Kei Murayama; Tohru Yorifuji; Kunihiko Kobayashi; Masaki Kanazawa; Atsushi Ogawa; Masaki Takayanagi
Journal:  Eur J Pediatr       Date:  2007-01-06       Impact factor: 3.183

2.  Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver.

Authors:  Kouichi Nakamura; Rick Moore; Masahiko Negishi; Tatsuya Sueyoshi
Journal:  J Biol Chem       Date:  2007-01-30       Impact factor: 5.157

3.  Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.

Authors:  Hironori Nagasaka; Tohru Yorifuji; Kei Murayama; Mitsuru Kubota; Keiji Kurokawa; Tomoko Murakami; Masaki Kanazawa; Tomozumi Takatani; Atsushi Ogawa; Emi Ogawa; Shigenori Yamamoto; Masanori Adachi; Kunihiko Kobayashi; Masaki Takayanagi
Journal:  Eur J Pediatr       Date:  2006-05-16       Impact factor: 3.183

4.  Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein.

Authors:  James P Warne; Jillian M Varonin; Sofie S Nielsen; Louise E Olofsson; Christopher B Kaelin; Streamson Chua; Gregory S Barsh; Suneil K Koliwad; Allison W Xu
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

5.  Role of PPARα in Hepatic Carbohydrate Metabolism.

Authors:  Annelies Peeters; Myriam Baes
Journal:  PPAR Res       Date:  2010-09-30       Impact factor: 4.964

6.  Protein localization as a principal feature of the etiology and comorbidity of genetic diseases.

Authors:  Solip Park; Jae-Seong Yang; Young-Eun Shin; Juyong Park; Sung Key Jang; Sanguk Kim
Journal:  Mol Syst Biol       Date:  2011-05-24       Impact factor: 11.429

7.  Recurrent abdominal pain, vomiting, velvet-like changes in the small intestine in a patient with multiple acyl-CoA dehydrogenase deficiency: a case report.

Authors:  Ziqing Ye; Jieru Shi; Xiaolan Lu; Yingying Meng; Wei Lu; Bingbing Wu; Ying Huang
Journal:  Transl Pediatr       Date:  2021-01

Review 8.  Potential therapeutic use of the ketogenic diet in autism spectrum disorders.

Authors:  Eleonora Napoli; Nadia Dueñas; Cecilia Giulivi
Journal:  Front Pediatr       Date:  2014-06-30       Impact factor: 3.418

9.  Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.

Authors:  Willemijn J van Rijt; Emmalie A Jager; Derk P Allersma; A Çiğdem Aktuğlu Zeybek; Kaustuv Bhattacharya; François-Guillaume Debray; Carolyn J Ellaway; Matthias Gautschi; Michael T Geraghty; David Gil-Ortega; Austin A Larson; Francesca Moore; Eva Morava; Andrew A Morris; Kimihiko Oishi; Manuel Schiff; Sabine Scholl-Bürgi; Michel C Tchan; Jerry Vockley; Peter Witters; Saskia B Wortmann; Francjan van Spronsen; Johan L K Van Hove; Terry G J Derks
Journal:  Genet Med       Date:  2020-01-06       Impact factor: 8.822

10.  Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency.

Authors:  Willemijn J van Rijt; Johan L K Van Hove; Frédéric M Vaz; Rick Havinga; Derk P Allersma; Tanja R Zijp; Jirair K Bedoyan; M R Heiner-Fokkema; Dirk-Jan Reijngoud; Michael T Geraghty; Ronald J A Wanders; Maaike H Oosterveer; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2021-02-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.